intelligent gate inc

123-03 23rd ave
college point, new york 11356

NYS Entity Status
ACTIVE

NYS Filing Date
AUGUST 07, 2014

NYS DOS ID#
4618415

County
QUEENS

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2014 - INTELLIGENT GATE INC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Amazon Cloud Customers Are Told: Don't Bypass China's Internet Gates
    Tuesday Aug 1, 2017

    Amazon.com Inc.’s web service partner in China, Beijing Sinnet Technology Co., has told Amazon cloud-computing customers to delete software tools that allow them to bypass China’s internet filters.

    Source: The Wall Street Journal: Technology: What's News
  • From Elon Musk to Bill Gates: Tech’s Most Dubious Promises
    By Ricki Harris - Wednesday Jul 26, 2017

    Elon Musk’s NY-DC hyperloop isn’t the first outrageous claim we’ve heard from Silicon Valley.

    Source: Webmonkey
  • Critic's Notebook: Contemporary Art Steams Up the Hudson
    By NANCY PRINCENTHAL - Thursday Aug 24, 2017

    Not your mother’s house tour: This summer has brought a bounty of artwork to Catskill, Hudson, Cold Spring and beyond.

    Source: NYT > Home Page
  • The Look: New York City Parks in the Summer: Romance, Games and a Performance for a Dying Tree
    By DANIEL ARNOLD, JOANNA NIKAS and EVE LYONS - Saturday Sep 2, 2017

    Daniel Arnold spent the last two months photographing parks in all five boroughs. The experience showed him “a very different pulse of the city.”

    Source: NYT > Home Page
  • Restaurant Review: Vegetables With Benefits at ABCV
    By PETE WELLS - Monday Jul 3, 2017

    The menu at Jean-Georges Vongerichten’s new vegetarian restaurant in the Flatiron district tries to impart “plant-based intelligence.”

    Source: NYT > Home Page
  • Abbvie’s hep C drug pricing threatens Gilead’s dominance
    By Max Nisen - Tuesday Aug 8, 2017

    Pharma already leads the business world in unpredictability, with billions in sales potentially riding on a few points of statistical significance in a clinical trial.[...] even within that context, a series of blockbuster medicines for hepatitis C have made for a roller-coaster ride for companies and investors.AbbVie Inc. last week threw another big curve at this market by pricing its newly FDA-approved drug Mavyret — which might be the most effective hepatitis C medicine approved yet — at a massive discount.Medicines from Johnson & Johnson, Merck & Co. Inc. and Vertex Pharmaceuticals Inc. approved within the past six years, which once booked billions in combined sales, are now essentially non-factors.After offering behind-the-scene discounts to insurance companies, pharmacy benefit managers and other payers, Mavyret’s price is actually not far from Harvoni’s, according to Bloomberg Intelligence.The real headache for Gilead — which already faces steep declines in hepatitis C drug sales because of increasing competition and the fact that many patients have been cured — lies in the fact that not all hepatitis patients or medicines are the same.AbbVie’s new drug can treat all of the major subtypes of hepatitis C. And it can cure the disease in many patients in just eight weeks.

    Source: SFGATE.com: Business and Technology News
intelligent gate inc college point ny